Artificial intelligence and computational modeling are increasingly transforming biotech research, from accelerating antiviral drug design against coronaviruses to enhancing antibody engineering with human-derived sequence data. AI-based screening techniques also enable thoracic aortic aneurysm detection from routine breast MRIs, exemplifying innovative diagnostic strategies. These advances underscore the integration of AI with biological data to improve therapeutic development and precision medicine, highlighting collaborations between leading academic and industry groups driving this digital revolution in life sciences.